0001214659-24-005217.txt : 20240326 0001214659-24-005217.hdr.sgml : 20240326 20240326202852 ACCESSION NUMBER: 0001214659-24-005217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240323 FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAZIMI A J CENTRAL INDEX KEY: 0001075050 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 24785463 MAIL ADDRESS: STREET 1: 1207 17TH AVENUE SUITE 103 CITY: NASHVILLE STATE: TN ZIP: 37212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-65385.xml PRIMARY DOCUMENT X0508 4 2024-03-23 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001075050 KAZIMI A J 1600 WEST END AVE. SUITE 1300 NASHVILLE TN 37203 true true true false Chairman and CEO 0 Common Stock 2024-03-23 4 F false 25710 1.81 D 5695557 D Options (right to buy) 1.88 2024-03-25 4 A false 100000 0 A 2028-03-25 2029-03-25 Stock Option 100000 368000 D This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. A.J. Kazimi by /s/ John Hamm as attorney-in-fact 2024-03-26